Pfizer acquires rights to Protalix’s Gaucher drug – Reuters
|
Pfizer acquires rights to Protalix's Gaucher drug
Reuters They had closed at $9.86 Monday on the American Stock Exchange. Pfizer shares were up nearly 1 percent in trading before the bell. … |
More: continued here